Hepatocarcinoma

Show results for

Unknown (468)
Transcriptomics (251)
Genomics (95)
Proteomics (29)
Metabolomics (4)
Methylation profiling (1)

Organisms

Homo sapiens (198)
Arabidopsis thaliana (32)
Mus musculus (28)
Andropogon gerardi (16)
Bacteria (16)
Bartonella quintana JK 31 (16)
Canis lupus familiaris (16)
Cnidaria (16)
Ensifer adhaerens (16)
Halictus scabiosae (16)
Human alphaherpesvirus 1 strain 17 (16)
Human alphaherpesvirus 1 strain KOS (16)
Human betaherpesvirus 5 (16)
Human herpesvirus 2 strain 186 (16)
Mesocricetus auratus (16)
Miscanthus x giganteus (16)
Mus musculus (16)
Panicum virgatum (16)
Platyhelminthes (16)
Pseudomonas aeruginosa PA103 (16)
Rabies virus Nishigahara RCEH (16)
Rattus norvegicus (6)
Candida albicans (3)
Capsella bursa-pastoris (2)
Solanum pimpinellifolium (1)
Euphorbia esula (1)
Malus domestica (1)
synthetic construct (1)
Gallus gallus (1)
Danio rerio (1)

Organisms

Homo sapiens (43)
Mus musculus (11)
Rattus norvegicus (1)

Repository

biostudies-arrayexpress (220)
ENA (78)
geo (45)
pride (16)
MassIVE (8)
iProX (5)
EGA (4)
GNPS (3)
MetaboLights (1)

Tissue

Hepatocyte (8)
Cell culture (7)
Liver (3)
Blood cell (1)
Blood plasma (1)
Colon (1)
Diploid cell (1)
Epithelial cell (1)
HeLa cell (1)
Permanent cell line cell (1)

Disease

Liver cancer (3)
Normal (2)
Adult hepatocellular carcinoma (1)
Disease free (1)
Hepatocellular carcinoma (1)
Inflammatory bowel disease (1)
Noonan syndrome (1)

Technology Type

Mass Spectrometry (16)
Shotgun proteomics (9)
Affinity purification coupled with mass spectrometry proteomics (3)
Bottom-up proteomics (2)
Gel-based experiment (2)
HiSeq X Ten (1)
Mass spectrometry (1)
Data-dependent acquisition (1)

Instrument Platform

Illumina HiSeq 2000 (8)
Illumina HiSeq 2500 (4)
NextSeq 550 (3)
Illumina NovaSeq 6000 (3)
Q Exactive (3)
NextSeq 500 (2)
6550 iFunnel Q-TOF LC/MS (2)
GC-MS (2)
LTQ Orbitrap Velos (2)
HISAT2, TOPHAT2 (1)
Illumina bead array Reader confocal scanner (1)
Axon- GenePix4000B (1)
Illumina NovaSeq X (1)
None (1)
BGISEQ-500 (1)
Illumina HiSeq 1500 (1)
Illumina HiSeq 4000 (1)
Orbitrap Fusion ETD (1)
TimsTOF Ultra 2 (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2015 (42)
2013 (34)
2014 (29)
2011 (26)
2010 (22)
2012 (19)
2016 (15)
2024 (14)
2025 (12)
2022 (12)
2021 (11)
2017 (9)
2008 (8)
2020 (7)
2009 (7)
2018 (6)
2023 (5)
2019 (5)
2007 (5)
2026 (4)
2006 (3)
2005 (2)
2003 (1)

Metabolite Name

Zoledronic acid (1)
Z-gly-pro (1)
Xipamide (1)
Xanthylic acid (XMP) (1)
Wogonin (1)
Wedelolactone (1)
Violacein (1)
Urushiol i (1)
Ubiquinone-10 (1)
Tyr-pro-phe(amide) (1)
Tyr-Lys (1)
Trp-Trp (1)
Tropisetron (1)
Triflusulfuron-methyl (1)
Trifloxysulfuron (1)
Tridecanoic acid (Tridecylic acid) (1)
Triclopyr (1)
Tricin methyl ether (1)
Trans-cinnamic acid (1)
Trans-carboxyglimepiride (1)
Tranilast (1)
Thyrotropin-releasing hormone (1)
Thiouric acid (1)
Thiosultap (1)
Thiorphan (1)
Thioglycolic acid solution (1)
Thieno[2,3-b]pyridine-5-carbonitrile, 6,7-dihydro-4-hydroxy-3-(2'-hydroxy[1,1'-biphenyl]-4-yl)-6-oxo- (1)
Thamnolic acid (1)
Tetradec-5-ynoic acid (1)
Teflubenzuron (1)

First Public Date

2021 (14)
2024 (11)
2022 (10)
2014 (8)
2015 (6)
2023 (5)
2025 (4)
2019 (4)
2018 (4)
2013 (4)
2020 (3)
2026 (2)
2016 (2)
2017 (1)

Modification

N6 (1)

Study type

Transcription profiling by array (147)
RNA-seq of coding RNA (28)
RNA-seq of non coding RNA (6)
Methylation profiling by array (5)
RNA-seq of total RNA (5)
ChIP-seq (4)
ChIP-chip by tiling array (3)
Comparative genomic hybridization by array (3)
Unknown experiment type (2)
Plant - High-throughput sequencing (2)
RNAi profiling by array (2)
ChIP-chip by array (2)
Other (2)
Methylation profiling by high throughput sequencing (2)
MicroRNA profiling by high-throughput sequencing (1)
High-throughput sequencing (1)
Cell line - High-throughput sequencing (1)
Genotyping by array (1)
RIP-seq (1)
MicroRNA profiling by array (1)
DNA-seq (1)

Release Date

2015 (64)
2023 (57)
2022 (57)
2021 (57)
2020 (47)
2013 (47)
2014 (46)
2019 (34)
2016 (34)
2017 (31)
2011 (31)
2012 (30)
2025 (29)
2018 (29)
2010 (24)
2024 (23)
2009 (10)
2008 (10)
2007 (7)
2026 (5)
2006 (5)
2005 (5)
2004 (2)
2000 (2)
2003 (1)
1999 (1)

Lab affiliation

Biochemistry and Molecular Biology Area Departament of Experimental biology University of Jaen (Spain) Campus Las Lagunillas, B3-356 23071, Jaén, Tel.: 953212523 (1)
Biochemistry and Molecular Biology Department, University of Córdoba (Spain) (1)
Chair, Dept of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada (1)
Department of Biochemistry and Molecular Biology, Protein Research Group, University of Southern Denmark (1)
Department of Biology, Johns Hopkins University, Baltimore, MD 21218 USA (1)
Department of Clinical Laboratory, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, China (1)
German Federal Institute for Risk Assessment (1)
IRCCS Istituto G Gaslini (1)
Institute of Biochemistry and Molecular Biology, National Taiwan University College of Medicine (1)
Karolinska Institutet, Stockholm, Sweden (1)
Protein Research Group Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark (1)
Proteomics Core Facility, Biozentrum, University of Basel, Switzerland (1)
VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium Department of Oncology, KU Leuven, Herestraat 49, Leuven, Belgium (1)
West China Hospital, Sichuan University (1)
shanghai municipal hospital of TCM (1)
xuzhu medical university (1)

Previous page
1 / 85
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 85
Next page

Sort by:

Relevance

Page size

PRDX6 as a promoter of cancer malignancy in hepatocarcinoma cell lines targeting GSK3B

This project describes the mechanism by wich PRDX6 affects migration and invasiveness in hepatocarcinoma cells. SNU475 (mesenchymal) hepatocarcinoma cell line knockout for PRDX6 showed a marked increase in ROS and lipid peroxidation, mytochondrial dysfunction, metabolic reprogramming, altered cytosk...

ORGANISM(S): Homo sapiens (Human)

2023-07-20 | PXD039491 | Pride

The function of Oxytocin Receptor in the Tumorigenesis of Hepatocarcinoma

PRJNA1048985 | ENA

Gene expression in PBMCs of patients with hepatocarcinoma: effect of ablative treatment - genes

PRJNA598857 | ENA

Human hepatocarcinoma cells : Huh-7 vs. SNU-739

Transcriptional profiling of human hepatocarcinoma comparing Huh-7 and SNU-739.

ORGANISM(S): Homo sapiens

2014-04-29 | GSE57106 | GEO

Gene expression in PBMCs of patients with hepatocarcinoma: effect of ablative treatment - genes

Gene expression profiles of PBMCs in patients with hepatocarcinoma after ablative treatment. Results provide the information of changes in PBMPs transcriptome following ablative treatment of hepatocarcinoma.

ORGANISM(S): Homo sapiens

2020-01-04 | GSE143004 | GEO

The function of Oxytocin Receptor in the Tumorigenesis of Hepatocarcinoma

To investigate the function of Oxytocin Receptor in the Tumorigenesis of Hepatocarcinoma.

ORGANISM(S): Homo sapiens

2024-01-31 | GSE249404 | GEO

Analysis of transcriptomic responses of genotoxic stress in human HepaRG hepatocarcinoma cells

PRJNA610841 | ENA

Human hepatocarcinoma cells : Huh-7 vs. SNU-739

Transcriptional profiling of human hepatocarcinoma comparing Huh-7 and SNU-739. Two-condition experiment, normalized ratio represented by Huh-7/SNU-739. Biological replicates: 2 Huh-7 replicates, 2 SNU-739 replicates.

ORGANISM(S): Homo sapiens

2014-04-29 | E-GEOD-57106 | biostudies-arrayexpress

Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase.

Not available

S-EPMC8487431 | biostudies-literature

Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma.

Not available

S-EPMC10629432 | biostudies-literature

Previous page
1 / 85
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 85
Next page

Sort by:

Relevance

Page size

848 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets